Dylan Morris is a Managing Director at Insight Partners, driven by a passion for accelerating biomedical innovation. With a background in computational neuroscience and biophysics, he began his career in startups, co-founding a biosensor company before transitioning to venture capital. Currently leading Insight's bio efforts, he is particularly interested in technology-enabled drug discovery, new therapeutic modalities, and curative therapies. Additionally, Dylan serves as a Board Director at DEM Biopharma, Inc., a company pioneering the next generation of immunotherapeutics to combat cancer.